Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	response to isolation stress	ACO2 TH SOD2	9.30e-07	4	128	3	GO:0035900
GeneOntologyBiologicalProcess	organelle assembly	FLII ERICH3 MYL2 USP9X ZNF423 FBF1 RTTN BECN2 TMOD4 HAUS3 IFT46 ODAD4 CRK CRKL TUBGCP6 PTK2B KIF15 KCNJ10 TPX2 PLEC JHY	6.79e-06	1138	128	21	GO:0070925
GeneOntologyBiologicalProcess	cell junction assembly	USP9X PCDHB5 FBF1 PCDHB6 PCDH17 CRK CRKL TAOK2 PTK2B FMN1 MACF1 PLEC PATJ	5.46e-05	569	128	13	GO:0034329
Domain	MAGEA3/MAGEA6	MAGEA3 MAGEA6	4.73e-05	2	129	2	IPR030097
Domain	IF5A_HYPUSINE	EIF5AL1 EIF5A	1.41e-04	3	129	2	PS00302
Domain	Transl_elong_IF5A_C	EIF5AL1 EIF5A	1.41e-04	3	129	2	IPR020189
Domain	Transl_elong_IF5A	EIF5AL1 EIF5A	1.41e-04	3	129	2	IPR001884
Domain	eIF-5a	EIF5AL1 EIF5A	1.41e-04	3	129	2	PF01287
Domain	Trans_elong_IF5A_hypusine_site	EIF5AL1 EIF5A	1.41e-04	3	129	2	IPR019769
Domain	eIF-5a	EIF5AL1 EIF5A	1.41e-04	3	129	2	SM01376
Domain	SH2	SHC3 CRK CRKL FYN VAV2	6.78e-04	101	129	5	PF00017
Domain	-	MACF1 PLEC	6.97e-04	6	129	2	3.90.1290.10
Domain	Plectin	MACF1 PLEC	9.72e-04	7	129	2	PF00681
Domain	Plectin_repeat	MACF1 PLEC	9.72e-04	7	129	2	IPR001101
Domain	PLEC	MACF1 PLEC	9.72e-04	7	129	2	SM00250
Domain	SH2	SHC3 CRK CRKL FYN VAV2	9.97e-04	110	129	5	SM00252
Domain	Znf_U1	ZNF385B ZNF385A ZFHX2	1.03e-03	29	129	3	IPR003604
Domain	ZnF_U1	ZNF385B ZNF385A ZFHX2	1.03e-03	29	129	3	SM00451
Domain	SH2	SHC3 CRK CRKL FYN VAV2	1.04e-03	111	129	5	PS50001
Domain	Cadherin_2	PCDHGA7 PCDHB5 PCDHB6 PCDH17	1.06e-03	65	129	4	PF08266
Domain	Cadherin_N	PCDHGA7 PCDHB5 PCDHB6 PCDH17	1.06e-03	65	129	4	IPR013164
Domain	SH2	SHC3 CRK CRKL FYN VAV2	1.08e-03	112	129	5	IPR000980
Domain	-	SHC3 CRK CRKL FYN VAV2	1.08e-03	112	129	5	3.30.505.10
Domain	BAH	TNRC18 BAHCC1	2.50e-03	11	129	2	PS51038
Domain	BAH_dom	TNRC18 BAHCC1	2.50e-03	11	129	2	IPR001025
Domain	BAH	TNRC18 BAHCC1	2.50e-03	11	129	2	SM00439
Domain	BAH	TNRC18 BAHCC1	2.50e-03	11	129	2	PF01426
Domain	Cadherin_C	PCDHGA7 PCDHB5 PCDHB6	3.04e-03	42	129	3	IPR032455
Domain	Cadherin_C_2	PCDHGA7 PCDHB5 PCDHB6	3.04e-03	42	129	3	PF16492
Domain	FH2	FMN1 FMN2	4.69e-03	15	129	2	PS51444
Domain	CRAL/TRIO_N_dom	MEIS3 CLVS1	4.69e-03	15	129	2	IPR011074
Domain	FH2_Formin	FMN1 FMN2	4.69e-03	15	129	2	IPR015425
Domain	FH2	FMN1 FMN2	4.69e-03	15	129	2	PF02181
Domain	FH2	FMN1 FMN2	4.69e-03	15	129	2	SM00498
Domain	Sushi	VCAN CSMD1 SEZ6	5.56e-03	52	129	3	PF00084
Domain	TPR-like_helical_dom	TANC2 COPB2 NASP SRP68 ODAD4 TTC39A	5.63e-03	233	129	6	IPR011990
Domain	Translation_prot_SH3-like	EIF5AL1 EIF5A	6.02e-03	17	129	2	IPR008991
Domain	CCP	VCAN CSMD1 SEZ6	6.18e-03	54	129	3	SM00032
Domain	Rib_L2_dom2	EIF5AL1 EIF5A	6.74e-03	18	129	2	IPR014722
Domain	ZF_MATRIN	ZNF385B ZNF385A	6.74e-03	18	129	2	PS50171
Domain	-	EIF5AL1 EIF5A	6.74e-03	18	129	2	2.30.30.30
Domain	SUSHI	VCAN CSMD1 SEZ6	6.83e-03	56	129	3	PS50923
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	FLII SERBP1 IRS4 USP9X POLR2B RPS8 COPB2 NASP SRP68 ACTL6A BANF1 PDIA4 XPNPEP3 NCAPD2 EIF5A MACF1 PLEC PATJ HNRNPR RAD23B	1.25e-08	1149	131	20	35446349
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SERBP1 IRS4 USP9X POLR2B NASP SRP68 ACTL6A GPRIN1 CRK CRKL YLPM1 TPX2 NCAPD2 PATJ	2.29e-08	549	131	14	38280479
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CWF19L2 SPOCK1 ACO2 ZNF423 POLR2B RPS8 COPB2 SRP68 ACTL6A IWS1 SACS VCAN XPNPEP3 YLPM1 MACF1 PLEC CBX8 AFF4 HNRNPR	2.61e-08	1082	131	19	38697112
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	FLII SERBP1 IRS4 ZFYVE16 USP9X POLR2B RPS8 COPB2 NASP SRP68 IFT46 ACTL6A MCM10 ISY1 CRKL RCOR1 UFD1 EIF5A HSP90AB2P HNRNPR RAD23B	2.95e-08	1335	131	21	29229926
Pubmed	Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-I receptor-mediated signal transduction.	IRS4 CRK CRKL	5.22e-08	3	131	3	9614078
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	TET2 FLII SERBP1 ACO2 ICAM1 RPS8 COPB2 SRP68 PDIA4 ACSL3 EIF5A MACF1 PLEC CBX8 HNRNPR	8.40e-08	711	131	15	33022573
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TANC2 FLII SERBP1 CNST USP9X ACO2 COPB2 CPZ GPRIN1 CRKL TAOK2 ACSL3 EIF5AL1 TNRC18 EIF5A MACF1 PLEC SOD2	2.98e-07	1139	131	18	36417873
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	FLII IRS4 USP9X POLR2B RPS8 CRKL PDIA4 ACSL3 SACS XPNPEP3 YLPM1 EIF5A MKI67 MACF1 PLEC FYN HNRNPR	3.31e-07	1024	131	17	24711643
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	IRS4 SPOCK1 PCDHGA7 ACO2 FBF1 DGKA PDE10A BANF1 PDIA4 ACSL3 USP8 TNRC18 PHF20L1 SACS YLPM1 NCAPD2 MACF1 PLEC HNRNPR BAHCC1	4.85e-07	1442	131	20	35575683
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	SERBP1 ZFYVE16 USP9X RPS8 COPB2 SRP68 GPRIN1 CRK CRKL PDIA4 NCAPD2 EIF5A MACF1 PATJ	5.06e-07	708	131	14	39231216
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	FLII SERBP1 IRS4 ARID3A NASP ACTL6A ISY1 YLPM1 TPX2 EIF5A MKI67 FMN2	5.24e-07	506	131	12	30890647
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	FLII SERBP1 USP9X POLR2B RPS8 COPB2 NASP SRP68 IWS1 PDIA4 USP8 KIF15 UFD1 NCAPD2 EIF5A MACF1 HSP90AB2P PLEC HNRNPR RAD23B	5.58e-07	1455	131	20	22863883
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CNST POLR2B COPB2 AKNAD1 NASP DGKA PDIA4 RCOR1 FMN1 VCAN FMN2 MACF1 PLEC PATJ RNF122 AFF4 STK25	7.27e-07	1084	131	17	11544199
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	ZFYVE16 ACO2 RPS8 COPB2 CRK CRKL RCOR1 UFD1 NCAPD2	8.46e-07	267	131	9	33417871
Pubmed	Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G.	CRK CRKL FYN	1.04e-06	6	131	3	8626543
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	FLII ZFYVE16 POLR2B NASP SRP68 HAUS3 MCM10 BANF1 IWS1 RCOR1 TPX2 CBX8 RAD23B	1.07e-06	645	131	13	25281560
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	HIP1 IRS4 ZFYVE16 FBF1 RPS8 NASP SRP68 CRK CRKL NCAPD2 EIF5A	1.16e-06	449	131	11	31732153
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	SERBP1 POLR2B COPB2 BANF1 ISY1 CRK IWS1 RCOR1 UFD1 YLPM1 TPX2 NCAPD2 EIF5A MKI67 PLEC RAD23B	1.46e-06	1014	131	16	32416067
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	FLII SERBP1 USP9X POLR2B RPS8 COPB2 SRP68 ISY1 CRKL IWS1 USP8 UFD1 XPNPEP3 NCAPD2 EIF5A MACF1 HSP90AB2P PLEC HNRNPR	1.56e-06	1415	131	19	28515276
Pubmed	SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.	FLII SERBP1 IRS4 RPS8 NASP PDIA4 TPX2 EIF5A MKI67 HSP90AB2P HNRNPR	1.57e-06	463	131	11	34901782
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SERBP1 ZFYVE16 GPRIN1 CRK CRKL USP8 FMN1 EIF5A PALM3 MACF1 PLEC PATJ	1.65e-06	565	131	12	25468996
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	SERBP1 ICAM1 COPB2 HAUS3 ACTL6A PDIA4 TUBGCP6 RCOR1 PHF20L1 YLPM1 TPX2 EIF5A MKI67 FYN HNRNPR STK25 RAD23B	1.72e-06	1155	131	17	20360068
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FLII SERBP1 IRS4 USP9X ACO2 POLR2B RPS8 COPB2 NASP SRP68 ACTL6A CRKL PDIA4 ACSL3 NCAPD2 EIF5A MKI67 HNRNPR RAD23B	1.73e-06	1425	131	19	30948266
Pubmed	Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.	CRK CRKL VAV2	1.81e-06	7	131	3	8621483
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	IRS4 USP9X POLR2B COPB2 SRP68 ACTL6A BANF1 ACSL3 NCAPD2 EIF5A PATJ RAD23B	1.84e-06	571	131	12	37167062
Pubmed	Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1.	SHC3 CRK CRKL VAV2	1.93e-06	24	131	4	20624904
Pubmed	USP7 controls NGN3 stability and pancreatic endocrine lineage development.	RPS8 COPB2 MKI67 MACF1 PLEC	2.74e-06	58	131	5	37117185
Pubmed	Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.	CRK CRKL FYN	2.88e-06	8	131	3	9315092
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	FLII SERBP1 ACO2 POLR2B RPS8 COPB2 DAB2 SRP68 SHC3 PDIA4 TPX2 MKI67 PLEC FYN HNRNPR	3.12e-06	949	131	15	36574265
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	HIP1 SERBP1 POLR2B SRP68 ZNF385A BANF1 IWS1 TAOK2 HARS2 TPX2 NCAPD2 PALM3 MACF1 HSP90AB2P PATJ PDLIM2 CBX8 AFF4 RAD23B	3.54e-06	1497	131	19	31527615
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	FLII SERBP1 COPB2 SRP68 HAUS3 ISY1 PDIA4 YLPM1 EIF5A MKI67 MACF1 PLEC HNRNPR	3.79e-06	724	131	13	36232890
Pubmed	ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling.	CRK CRKL FYN	4.31e-06	9	131	3	28086240
Pubmed	Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.	SERBP1 IRS4 MYL2 USP9X RPS8 COPB2 CRK CRKL XPNPEP3 PLEC	4.48e-06	418	131	10	32552912
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	FLII SERBP1 ACO2 POLR2B RPS8 COPB2 SRP68 ACTL6A ISY1 RCOR1 TNRC18 MKI67 PATJ FYN AFF4 HNRNPR RAD23B	4.78e-06	1247	131	17	27684187
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	USP9X COPB2 DAB2 SRP68 TPX2 NCAPD2 EIF5A PLEC HNRNPR	5.03e-06	332	131	9	32786267
Pubmed	Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3.	SERBP1 ACO2 RPS8 NASP BANF1 EIF5AL1 ZBTB39 EIF5A ZFHX2	5.03e-06	332	131	9	30595499
Pubmed	A protein interaction landscape of breast cancer.	USP9X ACO2 ICAM1 DAB2 SRP68 ACTL6A MCM10 MKI67 MACF1 CBX8 HNRNPR RAD23B	5.37e-06	634	131	12	34591612
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	IRS4 USP9X ACO2 NASP SRP68 PDIA4 HNRNPR	5.55e-06	179	131	7	36261009
Pubmed	Deficiency of CPEB2-Confined Choline Acetyltransferase Expression in the Dorsal Motor Nucleus of Vagus Causes Hyperactivated Parasympathetic Signaling-Associated Bronchoconstriction.	CPEB2 MYL2 TH	6.15e-06	10	131	3	27810937
Pubmed	Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins.	CRK CRKL FYN	6.15e-06	10	131	3	8662998
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	FLII SERBP1 POLR2B RPS8 COPB2 SRP68 ACTL6A MCM10 TPX2 MKI67 MACF1 CBX8 HNRNPR	6.30e-06	759	131	13	35915203
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	FLII USP9X COPB2 NASP SRP68 IWS1 PDIA4 ACSL3 UFD1 YLPM1 TPX2 HNRNPR	7.22e-06	653	131	12	33742100
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SERBP1 IRS4 USP9X COPB2 SRP68 PDIA4 ACSL3 YLPM1 NCAPD2 MKI67 MACF1 PLEC	7.22e-06	653	131	12	22586326
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TET2 SERBP1 RPS8 SRP68 BANF1 CRKL RCOR1 TNRC18 YLPM1 MKI67 PLEC HNRNPR	7.45e-06	655	131	12	35819319
Pubmed	Interaction network of human early embryonic transcription factors.	TET2 ARID3A ZNF423 ACTL6A PDIA4 RCOR1 TNRC18 MKI67 BAHCC1	7.87e-06	351	131	9	38297188
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	TANC2 FLII CNST POLR2B RPS8 BANF1 TPX2 MKI67 PLEC	9.85e-06	361	131	9	30344098
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	IRS4 ZFYVE16 USP9X POLR2B COPB2 GPRIN1 BANF1 IWS1 PDIA4 ACSL3 KIF15 YLPM1 MKI67 FMN2 CBX8	1.03e-05	1049	131	15	27880917
Pubmed	Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.	CRK CRKL PTK2B	1.12e-05	12	131	3	35192416
Pubmed	Grit, a GTPase-activating protein for the Rho family, regulates neurite extension through association with the TrkA receptor and N-Shc and CrkL/Crk adapter molecules.	SHC3 CRK CRKL	1.12e-05	12	131	3	12446789
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	SERBP1 IRS4 MYL2 SPOCK1 ACO2 RPS8 COPB2 PDIA4 UFD1 EIF5A MACF1 PLEC VAV2	1.21e-05	807	131	13	30575818
Pubmed	Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma.	CRK CRKL	1.41e-05	2	131	2	21319228
Pubmed	Comparison of Human Eukaryotic Translation Initiation Factors 5A1 and 5AL1: Identification of Amino Acid Residues Important for EIF5A1 Lysine 50 Hypusination and Its Protein Stability.	EIF5AL1 EIF5A	1.41e-05	2	131	2	37047039
Pubmed	Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway.	CRK CRKL	1.41e-05	2	131	2	19074029
Pubmed	Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.	CRK CRKL	1.41e-05	2	131	2	22569336
Pubmed	Physiological signals and oncogenesis mediated through Crk family adapter proteins.	CRK CRKL	1.41e-05	2	131	2	10092207
Pubmed	Crk1/2 and CrkL form a hetero-oligomer and functionally complement each other during podocyte morphogenesis.	CRK CRKL	1.41e-05	2	131	2	24499776
Pubmed	miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling.	MAGEA3 MAGEA6	1.41e-05	2	131	2	30056111
Pubmed	Polyamines and eIF5A Hypusination Modulate Mitochondrial Respiration and Macrophage Activation.	EIF5AL1 EIF5A	1.41e-05	2	131	2	31130465
Pubmed	Tyrosine hydroxylase and DOPA decarboxylase gene variants in personality traits.	DDC TH	1.41e-05	2	131	2	19221445
Pubmed	A region-dependent allele-biased expression of Dopa decarboxylase in mouse brain.	DDC TH	1.41e-05	2	131	2	36568970
Pubmed	The N-terminal region of eukaryotic translation initiation factor 5A signals to nuclear localization of the protein.	EIF5AL1 EIF5A	1.41e-05	2	131	2	17707773
Pubmed	Proteomic analysis of ubiquitin-proteasome effects: insight into the function of eukaryotic initiation factor 5A.	EIF5AL1 EIF5A	1.41e-05	2	131	2	12894223
Pubmed	The ability to induce microtubule acetylation is a general feature of formin proteins.	FMN1 FMN2	1.41e-05	2	131	2	23110170
Pubmed	Tyrosine phosphorylation of murine Crkl.	CRK CRKL	1.41e-05	2	131	2	7478571
Pubmed	Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).	CRK CRKL	1.41e-05	2	131	2	27807028
Pubmed	CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.	CRK CRKL	1.41e-05	2	131	2	38683131
Pubmed	Dopa decarboxylase and tyrosine hydroxylase gene variants in suicidal behavior.	DDC TH	1.41e-05	2	131	2	17948905
Pubmed	Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.	CRK CRKL	1.41e-05	2	131	2	33561443
Pubmed	mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.	DDC TH	1.41e-05	2	131	2	18814238
Pubmed	Crk and CrkL are required for cell transformation by v-fos and v-ras.	CRK CRKL	1.41e-05	2	131	2	25557916
Pubmed	Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling.	CRK CRKL	1.41e-05	2	131	2	18165234
Pubmed	Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling.	PTK2B FYN	1.41e-05	2	131	2	9104812
Pubmed	Exosomal EIF5A derived from Lewis lung carcinoma induced adipocyte wasting in cancer cachexia.	EIF5AL1 EIF5A	1.41e-05	2	131	2	37743008
Pubmed	Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.	CRK CRKL	1.41e-05	2	131	2	22251701
Pubmed	Non-catalytic functions of Pyk2 and Fyn regulate late stage adhesion in human T cells.	PTK2B FYN	1.41e-05	2	131	2	23300847
Pubmed	The forkhead-associated domain of Ki-67 antigen interacts with the novel kinesin-like protein Hklp2.	KIF15 MKI67	1.41e-05	2	131	2	10878014
Pubmed	Requirement for Crk and CrkL during postnatal lens development.	CRK CRKL	1.41e-05	2	131	2	32736680
Pubmed	Independent roles of eIF5A and polyamines in cell proliferation.	EIF5AL1 EIF5A	1.41e-05	2	131	2	15377278
Pubmed	Sequence determination and cDNA cloning of eukaryotic initiation factor 4D, the hypusine-containing protein.	EIF5AL1 EIF5A	1.41e-05	2	131	2	2492279
Pubmed	Essential roles of Crk and CrkL in fibroblast structure and motility.	CRK CRKL	1.41e-05	2	131	2	24166500
Pubmed	Targeted inhibition of eIF5Ahpu suppresses tumor growth and polarization of M2-like tumor-associated macrophages in oral cancer.	EIF5AL1 EIF5A	1.41e-05	2	131	2	37653021
Pubmed	Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.	CRK CRKL	1.41e-05	2	131	2	32147820
Pubmed	Identification of a new member of the human eIF-5A gene family.	EIF5AL1 EIF5A	1.41e-05	2	131	2	7622067
Pubmed	Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation.	EIF5AL1 EIF5A	1.41e-05	2	131	2	8253832
Pubmed	TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.	TET2 CSMD1	1.41e-05	2	131	2	25695618
Pubmed	Eukaryotic initiation factor 4D. Purification from human red blood cells and the sequence of amino acids around its single hypusine residue.	EIF5AL1 EIF5A	1.41e-05	2	131	2	3095320
Pubmed	A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.	MAGEA3 MAGEA6	1.41e-05	2	131	2	25564441
Pubmed	Identification of the regulatory network and potential markers for type 2 diabetes mellitus related to internal exposure to metals in Chinese adults.	ICAM1 SOD2	1.41e-05	2	131	2	36811699
Pubmed	Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A).	EIF5AL1 EIF5A	1.41e-05	2	131	2	11742107
Pubmed	The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.	EIF5AL1 EIF5A	1.41e-05	2	131	2	20501948
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	CWF19L2 SERBP1 ARID3A ACO2 POLR2B ACTL6A BANF1 ISY1 EIF5AL1 YLPM1 EIF5A PLEC	1.46e-05	701	131	12	30196744
Pubmed	The functional interactome landscape of the human histone deacetylase family.	USP9X POLR2B ACTL6A RCOR1 TNRC18 YLPM1 TPX2 MKI67	1.48e-05	289	131	8	23752268
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	FLII RPS8 COPB2 SRP68 PDIA4 TPX2 MKI67 HSP90AB2P PLEC HNRNPR	1.90e-05	494	131	10	26831064
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	SERBP1 USP9X POLR2B RPS8 ACTL6A ISY1 IWS1 TUBGCP6	1.93e-05	300	131	8	28561026
Pubmed	Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.	SERBP1 FBXL8 RPS8 COPB2 NASP CRKL PDIA4 EIF5A BAHCC1 RAD23B	1.94e-05	495	131	10	28581483
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	SERBP1 USP9X RPS8 NASP HAUS3 ACTL6A BANF1 PDIA4 HARS2 NCAPD2 MACF1 HSP90AB2P PLEC	2.00e-05	847	131	13	35235311
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ARID3A NASP ACTL6A MCM10 IWS1 PHF20L1 TPX2 MKI67 CBX8 AFF4 RAD23B	2.04e-05	608	131	11	36089195
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TANC2 POLR2B FBF1 ACTL6A ISY1 SLC5A11 TUBGCP6 RCOR1 FMN2 MACF1 TTC39A CSMD1 PDLIM2 AFF4 BAHCC1	2.13e-05	1116	131	15	31753913
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	FLII SERBP1 IRS4 USP9X POLR2B RPS8 COPB2 NASP ACTL6A ACSL3 UFD1 EIF5A HSP90AB2P HNRNPR STK25 RAD23B	2.16e-05	1257	131	16	37317656
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	NASP YLPM1 TPX2 MKI67 AFF4 HNRNPR	2.16e-05	148	131	6	32538781
Interaction	KCNA3 interactions	SERBP1 IRS4 ZFYVE16 USP9X RPS8 COPB2 AKNAD1 SRP68 GPRIN1 SHC3 CRK CRKL PDIA4 KCNA5 NCAPD2 EIF5A MACF1 PATJ FYN TDRD12	6.84e-07	871	129	20	int:KCNA3
Interaction	SYNGAP1 interactions	TANC2 SERBP1 ACO2 COPB2 CPZ GPRIN1 CRK TAOK2 PTK2B KCNJ10 EIF5A	4.63e-06	307	129	11	int:SYNGAP1
Interaction	KBTBD4 interactions	ZFYVE16 ACO2 POLR2B RPS8 COPB2 CRK CRKL PM20D2 RCOR1 UFD1 NCAPD2	6.09e-06	316	129	11	int:KBTBD4
Interaction	CEBPB interactions	FLII SERBP1 ARID3A POLR2B RPS8 COPB2 NASP SRP68 ACTL6A BANF1 ISY1 IWS1 PM20D2 PDIA4 RCOR1 YLPM1 TPX2 EIF5A MKI67 HSP90AB2P PLEC CBX8 SOD2 HNRNPR	1.35e-05	1443	129	24	int:CEBPB
Interaction	MECP2 interactions	CWF19L2 SPOCK1 ACO2 ZNF423 POLR2B RPS8 COPB2 SRP68 ACTL6A ISY1 IWS1 RCOR1 SACS VCAN XPNPEP3 YLPM1 MKI67 MACF1 PLEC CBX8 AFF4 HNRNPR	2.16e-05	1287	129	22	int:MECP2
Interaction	HUWE1 interactions	SERBP1 IRS4 USP9X ACO2 POLR2B RPS8 COPB2 NASP SRP68 ACTL6A BANF1 CRK CRKL ACSL3 RCOR1 UFD1 NCAPD2 EIF5A MACF1 RAD23B	2.56e-05	1110	129	20	int:HUWE1
Interaction	SUMO2 interactions	USP9X ACO2 COPB2 DAB2 SRP68 PDIA4 RCOR1 ZBTB39 TPX2 NCAPD2 EIF5A MKI67 PLEC HNRNPR	2.63e-05	591	129	14	int:SUMO2
Interaction	CDH1 interactions	SERBP1 ZFYVE16 SPOCK1 USP9X GPRIN1 CRK CRKL USP8 FMN1 EIF5A MKI67 PALM3 MACF1 PLEC PATJ FYN	3.25e-05	768	129	16	int:CDH1
Interaction	CHMP4C interactions	SERBP1 RPS8 COPB2 NASP SRP68 ACTL6A BANF1 PDIA4 USP8 XPNPEP3 EIF5A MKI67 MACF1 HNRNPR STK25	3.43e-05	687	129	15	int:CHMP4C
Interaction	MAGEL2 interactions	SERBP1 IRS4 NASP CRKL USP8	4.44e-05	61	129	5	int:MAGEL2
Interaction	PEAK3 interactions	CRK CRKL PTK2B	5.40e-05	12	129	3	int:PEAK3
Interaction	H2BC5 interactions	HIP1 SERBP1 PCDHGA7 ICAM1 FBF1 MCM10 PDIA4 TNRC18 PHF20L1 MKI67	5.45e-05	331	129	10	int:H2BC5
Interaction	GRB2 interactions	SERBP1 IRS4 PCDHB5 FBF1 DAB2 ACTL6A SHC3 CRK CRKL PTK2B USP8 PACRGL YLPM1 PLEC FYN VAV2	5.78e-05	806	129	16	int:GRB2
Interaction	HDAC1 interactions	MAGEA3 TET2 FLII IRS4 ZFYVE16 ZNF423 ACTL6A BANF1 CRK CRKL RCOR1 TNRC18 KIF15 PHF20L1 NCAPD2 MKI67 PLEC HNRNPR BAHCC1	8.08e-05	1108	129	19	int:HDAC1
Interaction	LRRK2 interactions	RPS8 COPB2 NASP CRKL PDIA4 PHF20L1 UFD1 EIF5A PLEC AFF4 JHY STK25	8.35e-05	496	129	12	int:LRRK2
Interaction	RECQL4 interactions	FLII SERBP1 IRS4 ZFYVE16 USP9X POLR2B RPS8 COPB2 NASP SRP68 IFT46 ACTL6A MCM10 ISY1 CRKL RCOR1 UFD1 EIF5A HSP90AB2P PLEC HNRNPR RAD23B	8.66e-05	1412	129	22	int:RECQL4
Interaction	BAP1 interactions	FLII SERBP1 IRS4 USP9X POLR2B RPS8 COPB2 NASP SRP68 ACTL6A BANF1 PDIA4 RCOR1 XPNPEP3 NCAPD2 EIF5A MACF1 PLEC PATJ HNRNPR RAD23B	8.97e-05	1314	129	21	int:BAP1
Interaction	TNIP1 interactions	FLII SERBP1 ACO2 POLR2B FBF1 RPS8 COPB2 DAB2 SRP68 MCM10 SHC3 BANF1 PDIA4 RCOR1 TPX2 MKI67 TTC39A PLEC FYN HNRNPR	9.23e-05	1217	129	20	int:TNIP1
Interaction	KIF23 interactions	SERBP1 RTTN RPS8 SRP68 BANF1 CRKL ACSL3 USP8 EIF5AL1 TNRC18 XPNPEP3 MKI67 MACF1 HSP90AB2P PLEC FYN AFF4 HNRNPR	1.01e-04	1031	129	18	int:KIF23
Interaction	RBBP7 interactions	TET2 FLII SERBP1 ZNF423 NASP ACTL6A BANF1 RCOR1 TNRC18 PHF20L1 NCAPD2 BAHCC1	1.03e-04	507	129	12	int:RBBP7
Interaction	PDGFRB interactions	HIP1 ZFYVE16 CRK CRKL PDIA4 USP8 FYN VAV2	1.12e-04	228	129	8	int:PDGFRB
Interaction	PALM3 interactions	MAGEA3 POLR2B PALM3	1.35e-04	16	129	3	int:PALM3
Interaction	ACTC1 interactions	MAGEA3 FLII SERBP1 IRS4 ARID3A NASP ACTL6A ISY1 YLPM1 TPX2 EIF5A MKI67 FMN2 PLEC	1.46e-04	694	129	14	int:ACTC1
Interaction	FGFR2 interactions	ZFYVE16 BANF1 CRKL IWS1 PTK2B USP8 FYN PDLIM2	1.55e-04	239	129	8	int:FGFR2
Interaction	FLT1 interactions	USP9X BANF1 CRK CRKL PDIA4 PTK2B FYN	1.56e-04	179	129	7	int:FLT1
Interaction	ECT2 interactions	FLII CWF19L2 SERBP1 USP9X RPS8 SRP68 BANF1 ACSL3 KCNJ10 NCAPD2 MKI67 MACF1 HSP90AB2P PLEC FYN HNRNPR	1.75e-04	887	129	16	int:ECT2
Interaction	NCAPH interactions	FLII SERBP1 RPS8 NASP RCOR1 NCAPD2 EIF5A MKI67 PLEC	1.97e-04	315	129	9	int:NCAPH
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	SPOCK1 PCDHGA7 PCDHB5 PCDHB6 HARS2 AFF4	2.16e-04	298	130	6	chr5q31
Cytoband	5q31	PCDHGA7 PCDHB5 PCDHB6 AFF4	3.33e-04	115	130	4	5q31
Cytoband	4p15.33	CPEB2 HSP90AB2P	6.08e-04	13	130	2	4p15.33
GeneFamily	SH2 domain containing	SHC3 CRK CRKL FYN VAV2	1.07e-04	101	84	5	741
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ZFYVE16 CNST SACS YLPM1 MKI67 CSMD1	1.97e-04	181	84	6	694
GeneFamily	EF-hand domain containing\|Plakins	MACF1 PLEC	5.86e-04	8	84	2	939
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TANC2 NASP ODAD4 TTC39A	2.03e-03	115	84	4	769
GeneFamily	Ubiquitin specific peptidases	USP9X USP8 USP40	2.25e-03	56	84	3	366
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	VCAN CSMD1 SEZ6	2.36e-03	57	84	3	1179
GeneFamily	Clustered protocadherins	PCDHGA7 PCDHB5 PCDHB6	3.29e-03	64	84	3	20
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE	TET2 FLII HIP1 ANGPT1 ARID3A ACO2 FAAP24 ICAM1 ZNF385A CRK IER2 USP8 RCOR1 TNRC18 ADIPOR1 KCNA5 P2RX1 RNF122 VAV2 CBX8 SOD2 BAHCC1 RAD23B	3.72e-08	1250	128	23	M41099
Coexpression	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	SERBP1 CRK ACSL3 USP8 RCOR1 SACS VCAN FYN RAD23B	7.95e-06	272	128	9	M15123
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_UP	SERBP1 ARID3A RPS8 MCM10 DDC PDIA4 ACSL3 KIF15 TPX2 NCAPD2 MKI67 HNRNPR STK25	9.83e-06	612	128	13	M4772
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	TET2 ZFYVE16 PACRGL FMN1 NCAPD2 MACF1 PLA2G6	1.79e-05	166	128	7	M6826
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	CPEB2 TANC2 TET2 SERBP1 NBEAL1 RTTN DAB2 NASP DGKA TST PCDH17 YLPM1 FMN2 PLEC FYN PDLIM2 HNRNPR	2.68e-05	1102	128	17	M2369
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 NBEAL1 USP9X IWS1 KIF15 NCAPD2 MACF1	3.01e-05	180	128	7	M8239
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	CPEB2 TANC2 TET2 SERBP1 NBEAL1 RTTN DAB2 NASP DGKA TST PCDH17 YLPM1 FMN2 PLEC FYN PDLIM2 HNRNPR	3.44e-05	1124	128	17	MM1070
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN	TANC2 HIP1 ZFYVE16 COPB2 HAUS3 CRKL IWS1	5.01e-05	195	128	7	M9508
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	RTTN NASP HAUS3 DDC RCOR1 SACS FYN	5.88e-05	200	128	7	M9317
Coexpression	ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN	FLII ARID3A ACO2 HARS2 AFF4	6.16e-05	85	128	5	M41085
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	CWF19L2 SERBP1 IRS4 NASP ACTL6A MCM10 SENP8 PDE10A CLVS1 SHC3 IWS1 KIF15 TPX2 MKI67 PALM3 ZFHX2 FMN2 JHY	2.45e-05	989	127	18	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	HIP1 SERBP1 NASP PDE10A IWS1 KIF15 TPX2 JHY	3.19e-05	204	127	8	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	CWF19L2 IRS4 NASP SENP8 CLVS1 SHC3 IWS1 KIF15 TPX2 PALM3 FMN2 JHY	4.54e-05	498	127	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DAB2 HAUS3 RGS10 KIF15 KCNJ10 TPX2 NCAPD2 MKI67	3.41e-08	166	131	8	bb8135119dc37fdbba476599a56d368f422688dc
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	TANC2 DGKA RGS10 YLPM1 FYN RAD23B	1.97e-07	85	131	6	3f33e897eb030043905a6a1a83377cd601652958
ToppCell	Basal-basal-4\|World / Class top	ICAM1 RPS8 TST PCDH17 IER2 EIF5A PDLIM2	6.23e-07	166	131	7	2721772eb2a9f45c5e9aaf4d73d198fea11a3586
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF423 NASP PCDH17 KIF15 TPX2 NCAPD2 MKI67	8.55e-07	174	131	7	c988471207ba06195bc3e41056435e8c31c20bbe
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2 MEIS3 MCM10 KIF15 TPX2 NCAPD2 MKI67	1.20e-06	183	131	7	e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NASP ACTL6A BANF1 KIF15 MKI67 RNF122 HNRNPR	1.43e-06	188	131	7	8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC\|lymph-node_spleen / Manually curated celltypes from each tissue	ARID3A DAB2 NIBAN3 KCNA5 P2RX1 TTC39A BAHCC1	1.49e-06	189	131	7	6c2ace61a7d62bcf7e76b73e2da8b722d03e713b
ToppCell	Control-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	TET2 ARID3A ZFYVE16 ACSL3 FMN1 VCAN SOD2	1.77e-06	194	131	7	c35bf04d5e7450cb6679a036fcabb1b28f409f29
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2 MCM10 KIF15 TPX2 NCAPD2 MKI67 PATJ	1.83e-06	195	131	7	c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CLVS1 PCDH17 ACSL3 KIF15 SACS TPX2 MKI67	2.02e-06	198	131	7	7225a6194c52b01c581e58d3cda107c4af96dc4f
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	NASP ACTL6A MCM10 PM20D2 KIF15 TPX2 MKI67	2.09e-06	199	131	7	3d876f172487425b37b2f658dae59e0f293ee76e
ToppCell	Severe-Developping_Plasmablast\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	COPB2 MCM10 PDIA4 KIF15 TPX2 NCAPD2 MKI67	2.16e-06	200	131	7	6d0cd00e52568d23597cc2a4059bd967d7d2dab5
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIP1 DAB2 TMOD4 VCAN MKI67 FMN2	6.17e-06	153	131	6	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	367C-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ZNF423 PHF7 ZNF385A KIF15 TPX2 MKI67	8.26e-06	161	131	6	c61283c301a87bb802f6f8ce79c26067032dd7d9
ToppCell	367C-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ZNF423 PHF7 ZNF385A KIF15 TPX2 MKI67	8.26e-06	161	131	6	9864d8b0929dacf4be7a4e97d2527ac3120ea264
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NASP MCM10 GPRIN1 KIF15 TPX2 MKI67	9.51e-06	165	131	6	88681101d7cf60b99b8ace5d8c0944323b937306
ToppCell	10x5'-Liver-Myeloid_Dendritic-pDC\|Liver / Manually curated celltypes from each tissue	MYL2 TMOD4 NIBAN3 KCNA5 P2RX1 TTC39A	9.84e-06	166	131	6	24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DGKA KIF15 TPX2 NCAPD2 MKI67 PALM3	1.02e-05	167	131	6	754e6412d3b9cc0b126e59593df2f5956b4712ef
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SENP8 RGS10 KIF15 TPX2 NCAPD2 MKI67	1.05e-05	168	131	6	9b8a74abb83c64f0b5829dcb4275f722c82b45dc
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SENP8 RGS10 KIF15 TPX2 NCAPD2 MKI67	1.05e-05	168	131	6	4b152b8d0f4a66faf664dfacb7914b18d60ce64a
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SENP8 RGS10 KIF15 TPX2 NCAPD2 MKI67	1.05e-05	168	131	6	c3169ad8f4130ef18777ed86770bb722ffb5db85
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AKNAD1 MCM10 KIF15 VCAN TPX2 MKI67	1.16e-05	171	131	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AKNAD1 MCM10 KIF15 VCAN TPX2 MKI67	1.16e-05	171	131	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM10 KIF15 TPX2 NCAPD2 MKI67 BAHCC1	1.20e-05	172	131	6	35c20de4db47dbf31c857d23c7a25cd7f95c085c
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GPRIN1 KIF15 SACS TPX2 MKI67 TDRD12	1.24e-05	173	131	6	20889aa85e36ad3bafdb91b91e43964493c949f9
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GPRIN1 KIF15 SACS TPX2 MKI67 TDRD12	1.24e-05	173	131	6	46e601b7938b1dd0aa3df7aa056c4bd07b1620c1
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors\|lymph-node_spleen / Manually curated celltypes from each tissue	ANGPT1 KIF15 VCAN TPX2 MKI67 BAHCC1	1.29e-05	174	131	6	029394e107bf7ad58056d2216070aa2e964fff12
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	MCM10 GPRIN1 KIF15 TPX2 MKI67 TDRD12	1.33e-05	175	131	6	fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|368C / Donor, Lineage, Cell class and subclass (all cells)	MCM10 GPRIN1 KIF15 TPX2 MKI67 TDRD12	1.33e-05	175	131	6	36c140540497bbe1c5f08fac2d94f08cac18fabb
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4\|Striatum / BrainAtlas - Mouse McCarroll V32	MCM10 BANF1 KIF15 TPX2 NCAPD2 MKI67	1.37e-05	176	131	6	d70fdc7bc48719776ed1e7c01118385e3a21623f
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1\|Striatum / BrainAtlas - Mouse McCarroll V32	MCM10 BANF1 KIF15 TPX2 NCAPD2 MKI67	1.37e-05	176	131	6	a84361308e5e96f3a30246cd29e109c321ee65bf
ToppCell	Control-Developping_Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MCM10 TST PDIA4 KIF15 TPX2 MKI67	1.51e-05	179	131	6	9383568f78b07b8cca72ece5d15fea209aa54ea9
ToppCell	390C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	PHF7 MCM10 SENP8 KIF15 TPX2 MKI67	1.51e-05	179	131	6	e67ad7ab04d0c1309296f57c1f53c5ca14c213fe
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NASP BANF1 KIF15 TPX2 MKI67 HNRNPR	1.56e-05	180	131	6	44988c34861df359a68376500c42a64fbcc4b431
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 MEIS3 KIF15 TPX2 NCAPD2 MKI67	1.56e-05	180	131	6	43fd5c498a87bb078d101298b472656f3294686a
ToppCell	COPD-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	TET2 PTK2B FMN1 VCAN CSMD1 SOD2	1.76e-05	184	131	6	ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM10 SENP8 KIF15 NCAPD2 MKI67 TTC39A	1.76e-05	184	131	6	16aa8e88bdd51b1d132d5cf33c29963b384a8bae
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARID3A NIBAN3 KIF15 TPX2 NCAPD2 MKI67	1.76e-05	184	131	6	8f40093de5bb978f046d66e8f05f333686a009a4
ToppCell	3'_v3-blood-Lymphocytic_T_CD4/8-lo\|blood / Manually curated celltypes from each tissue	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	1.82e-05	185	131	6	df85ff34b796b403f2d0741771e9592e03657f6a
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|bone_marrow / Manually curated celltypes from each tissue	KIF15 VCAN TPX2 NCAPD2 MKI67 PLEC	1.88e-05	186	131	6	e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MCM10 PCDH17 KIF15 TPX2 MKI67 SEZ6	1.88e-05	186	131	6	4fe8e0bf74c7dbf73634cafdacad89020d2634d0
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPRIN1 SHC3 PCDH17 ZFHX2 FMN2 SEZ6	1.99e-05	188	131	6	9fd262bbf6cdebfd945e39428a6059726fb55b3a
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS8 KIF15 VCAN TPX2 NCAPD2 MKI67	1.99e-05	188	131	6	a6ad6de6aeaf213952124252c1452b73942a0c3d
ToppCell	3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T\|blood / Manually curated celltypes from each tissue	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	1.99e-05	188	131	6	714ccbcf826f26d39757931a3b8abbd952f4cddc
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPRIN1 SHC3 PCDH17 ZFHX2 FMN2 SEZ6	1.99e-05	188	131	6	459e3fd4335a6f25f982d011b38702f4fcfed1cd
ToppCell	COPD-Myeloid-cMonocyte\|COPD / Disease state, Lineage and Cell class	TET2 ACSL3 PTK2B FMN1 VCAN SOD2	2.05e-05	189	131	6	d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T\|GI_small-bowel / Manually curated celltypes from each tissue	ANGPT1 MCM10 KIF15 TPX2 NCAPD2 MKI67	2.18e-05	191	131	6	e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell	Striatum-Macroglia-POLYDENDROCYTE\|Striatum / BrainAtlas - Mouse McCarroll V32	NASP ACTL6A MCM10 KIF15 MKI67 RNF122	2.18e-05	191	131	6	6bc9c7c86040f3ebce08c350e625e345581d4550
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAUS3 MCM10 KIF15 TPX2 NCAPD2 MKI67	2.24e-05	192	131	6	e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MCM10 KIF15 TPX2 NCAPD2 MKI67 TDRD12	2.31e-05	193	131	6	81e6240cffb094b2aa3684fd0889b6497f47c4f0
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RPS8 KIF15 VCAN TPX2 NCAPD2 MKI67	2.31e-05	193	131	6	4a3e456f07e521519faeb9153e8d571cb8fbeaf9
ToppCell	3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.38e-05	194	131	6	a8ae49157ca3f9e8b3f1750a995aee012dc859b6
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARID3A MCM10 PDIA4 KIF15 TPX2 MKI67	2.38e-05	194	131	6	ffba703f61faaac8b4b9a5e46cd335214303de7b
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	TET2 ACSL3 PTK2B FMN1 CSMD1 SOD2	2.38e-05	194	131	6	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 KIF15 TPX2 NCAPD2 MKI67 PATJ	2.38e-05	194	131	6	effd38e51062b225ecabc7e1c50154e65495d559
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RPS8 KIF15 VCAN TPX2 NCAPD2 MKI67	2.38e-05	194	131	6	5810d8e1f6b983bb346fe06dda22b8ba3f2144a6
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MCM10 PCDH17 KIF15 TPX2 NCAPD2 MKI67	2.38e-05	194	131	6	3a49c7c86036e09a8cd0114988380d04ad1a26fb
ToppCell	356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ANGPT1 MCM10 P2RX1 KIF15 TPX2 MKI67	2.45e-05	195	131	6	751cb00b0f3005be6b645adadfbb9dd2215b6e08
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NASP HAUS3 KIF15 TPX2 NCAPD2 MKI67	2.45e-05	195	131	6	97b2ff072cc830a4a2cb217f5a215ca6cad505ec
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HIP1 NASP MKI67 FYN HNRNPR SEZ6	2.52e-05	196	131	6	8faac7fbdee3a9297023c3151ef1751605413e44
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NASP HAUS3 KIF15 TPX2 NCAPD2 MKI67	2.52e-05	196	131	6	62b2de1d38a99ab23211bf51595845f8a1fdb7d2
ToppCell	myeloid-pro-pDC\|myeloid / Lineage and Cell class	NASP NIBAN3 KCNA5 TPX2 MKI67 BAHCC1	2.52e-05	196	131	6	70daf4fabb68aecc5cc9f03d6f6495dd29b74a16
ToppCell	3'-Adult-LargeIntestine\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NASP TST IER2 TPX2 MKI67 SOD2	2.59e-05	197	131	6	03646005921bc330b7a9f66889ef1a7b9a3d530e
ToppCell	myeloid-pro-pDC\|World / Lineage and Cell class	DAB2 NASP NIBAN3 KCNA5 MKI67 BAHCC1	2.59e-05	197	131	6	8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5
ToppCell	Transverse-T_cell-cycling_gd_T\|Transverse / Region, Cell class and subclass	MCM10 GPRIN1 KIF15 TPX2 NCAPD2 MKI67	2.67e-05	198	131	6	5131b0b7d6c4dd8872cef9f2e233f59f751b4690
ToppCell	severe-Myeloid-CD14_Monocytes_3\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPS8 ZNF385A BANF1 RGS10 VCAN EIF5A	2.67e-05	198	131	6	cb8f099cf4ed320615b1c60ddab86b89d8db9a43
ToppCell	Caecum-B_cell-B_cell_cycling\|Caecum / Region, Cell class and subclass	MCM10 KIF15 KCNJ10 TPX2 NCAPD2 MKI67	2.67e-05	198	131	6	61294fe99a5641ad359796022c3d038470076b3c
ToppCell	Transverse-(1)_T_cell-(18)_cycling_gd_T\|Transverse / shred on region, Cell_type, and subtype	MCM10 GPRIN1 KIF15 TPX2 NCAPD2 MKI67	2.67e-05	198	131	6	396dddf7ebad41c3a91329b6a280623c0dfdcd2f
ToppCell	Caecum-(2)_B_cell-(24)_B_cell_cycling\|Caecum / shred on region, Cell_type, and subtype	MCM10 KIF15 KCNJ10 TPX2 NCAPD2 MKI67	2.67e-05	198	131	6	568d47770cd20c6569ca84ea1eafde367642d68b
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.67e-05	198	131	6	281fc2536cdc4c717b30de156e563c0e4baba99d
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	e98ff036d04fc78dffef156bdc0d644532274067
ToppCell	343B-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SPOCK1 ZNF385A RGS10 PDIA4 VCAN RAD23B	2.74e-05	199	131	6	08c7e631b2e203dd7dcb75a7f9377d292bc5a0fd
ToppCell	343B-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SPOCK1 ZNF385A RGS10 PDIA4 VCAN RAD23B	2.74e-05	199	131	6	4338bf6cafc26c5d6497955d91914f84bacfacfa
ToppCell	18-Airway-Mesenchymal-Mesenchyme_RSPO2+\|Airway / Age, Tissue, Lineage and Cell class	KIF15 VCAN TPX2 NCAPD2 MKI67 MACF1	2.74e-05	199	131	6	7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af
ToppCell	(5)_Dendritic_cell-(52)_cycling_DCs\|(5)_Dendritic_cell / shred on Cell_type and subtype	DAB2 NASP KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	d0ff446a197062b10f37b585f3f8716d6d89e5b7
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NASP MCM10 KIF15 TPX2 MKI67 HNRNPR	2.74e-05	199	131	6	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	7feedb0bf84a3361c8ab5b6674ff64e8ff140c23
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	123fbf2122aa221d8cbf3aef9361ba0982c07695
ToppCell	B_cell_maturation-pre-B\|B_cell_maturation / Lineage and Cell class	NASP ACTL6A MCM10 KIF15 TPX2 MKI67	2.74e-05	199	131	6	4bf6a656de04d92103cbe743cd07afd9d125c654
ToppCell	Mild/Remission-Developping_Plasmablast\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MCM10 PDIA4 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	58c772ec763109a4009f52424fbb214fc23d0c09
ToppCell	COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Severe / Disease group, lineage and cell class	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6
ToppCell	severe-Lymphocytic-Prol._cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MCM10 BANF1 KIF15 TPX2 MKI67 HNRNPR	2.74e-05	199	131	6	b24315952b6ac6c8d2d3a7bd949a5b5392624d4e
ToppCell	Dividing_Macrophages\|World / lung cells shred on cell class, cell subclass, sample id	FAAP24 MCM10 KIF15 TPX2 NCAPD2 MKI67	2.74e-05	199	131	6	5c755b6876e164dc847ef7c723f850f227cf3a87
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	8f8b8c225cdc79baf16fe04be89bdb65e404a055
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells\|10w / Sample Type, Dataset, Time_group, and Cell type.	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell\|3m / Sample Type, Dataset, Time_group, and Cell type.	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	2938a029fa0478be561574ace91f95c4a528b2d4
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	TANC2 P2RX1 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Severe / Disease, condition lineage and cell class	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	0892603e604c2a945dd720685d45970f855bd5d3
ToppCell	Transverse-Dendritic_cell-cycling_DCs\|Dendritic_cell / Region, Cell class and subclass	DAB2 PDIA4 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	617a6a42f7b31eb3c45bdceaf55a591b6de7f154
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MCM10 KIF15 VCAN TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	dd5b753bb1333fa502b9d3a6d65a53a9882b2451
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells\|3m / Sample Type, Dataset, Time_group, and Cell type.	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	cfe017b4a4d604a553d0a3df9659687f38e9a7af
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	1fbed5967fc1922efe4a98f5760ad74fce210c52
ToppCell	Severe-T/NK_proliferative\|Severe / Disease group and Cell class	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	4723613a9f56bff422fc98722128d57b6adf3c5d
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	04bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCell	Severe-T/NK_proliferative\|World / Disease group and Cell class	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	128d82eb4d5760adf872212d8e8b5787a889969f
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined\|T/NK_cells / Location, Cell class and cell subclass	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	cfec2f712b870797fab3b0770f16feaafd37e8d5
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	NASP MCM10 KIF15 TPX2 NCAPD2 MKI67	2.82e-05	200	131	6	7e4c0db43a03ca11380a54f44a3cf1991e055b80
Drug	bromovanin	SERBP1 ISY1 UFD1 EIF5A PLEC HNRNPR RAD23B	8.09e-06	127	129	7	ctd:C515564
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	TANC2 HIP1 RGS10 TH PLA2G6 CBX8 AFF4 SOD2	1.64e-05	196	129	8	1708_UP
Drug	Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A	IRS4 DAB2 PDE10A TAOK2 PLA2G6 RNF122 FYN BAHCC1	1.70e-05	197	129	8	3390_UP
Drug	Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A	DGKA TH PLA2G6 PATJ VAV2 CBX8 AFF4 BAHCC1	1.70e-05	197	129	8	3334_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	FAAP24 PDE10A RGS10 PLA2G6 PATJ RNF122 FYN JHY	1.76e-05	198	129	8	2106_UP
Drug	Flecainide acetate [54143-56-5]; Up 200; 8.4uM; HL60; HT_HG-U133A	ICAM1 DAB2 DGKA PDE10A TAOK2 XPNPEP3 PLEC JHY	1.76e-05	198	129	8	2557_UP
Disease	Liver carcinoma	MAGEA3 MAGEA6 ACO2 MCM10 TST TH KIF15 GYS2 TPX2 MKI67 CSMD1 SOD2	2.09e-06	507	127	12	C2239176
Disease	cortical thickness	FLII ANGPT1 NBEAL1 ZNF423 ZNF385B PCDH17 CRK KCNA5 VCAN YLPM1 TPX2 FMN2 MACF1 PLEC CBX8 RAD23B	2.43e-05	1113	127	16	EFO_0004840
Disease	response to angiotensin-converting enzyme inhibitor, Cough	SPOCK1 KCNA5 GYS2 CSMD1	4.64e-05	46	127	4	EFO_0005325, HP_0012735
Disease	ovarian cancer (is_marker_for)	ANGPT1 ICAM1 NASP CRKL	2.15e-04	68	127	4	DOID:2394 (is_marker_for)
Disease	diabetic angiopathy (implicated_via_orthology)	ICAM1 PTK2B	2.73e-04	6	127	2	DOID:11713 (implicated_via_orthology)
Disease	melanoma (is_marker_for)	ICAM1 IER2 SOD2	3.87e-04	33	127	3	DOID:1909 (is_marker_for)
Disease	HOMA-IR	COPB2 RCOR1 CSMD1	3.87e-04	33	127	3	EFO_0004501
Disease	breast cancer (is_implicated_in)	ACSL3 PTK2B ADIPOR1 MKI67 SOD2	4.91e-04	150	127	5	DOID:1612 (is_implicated_in)
Disease	restless legs syndrome (implicated_via_orthology)	MEIS3 MEIS3P2	5.06e-04	8	127	2	DOID:0050425 (implicated_via_orthology)
Disease	sensorineural hearing loss (biomarker_via_orthology)	KCNJ10 SOD2	5.06e-04	8	127	2	DOID:10003 (biomarker_via_orthology)
Disease	diffuse large B-cell lymphoma (is_marker_for)	ICAM1 MKI67	5.06e-04	8	127	2	DOID:0050745 (is_marker_for)
Disease	Parkinson Disease	RPS8 DDC TH SOD2	5.06e-04	85	127	4	C0030567
Disease	brain measurement, neuroimaging measurement	ANGPT1 KCNA5 VCAN TPX2 MACF1 PLEC CBX8 BAHCC1 RAD23B	6.45e-04	550	127	9	EFO_0004346, EFO_0004464
Disease	velocardiofacial syndrome (implicated_via_orthology)	CRKL UFD1	6.49e-04	9	127	2	DOID:12583 (implicated_via_orthology)
Disease	myocardial infarction (biomarker_via_orthology)	ANGPT1 ICAM1 DAB2 VCAN SOD2	6.58e-04	160	127	5	DOID:5844 (biomarker_via_orthology)
Disease	response to carboplatin, response to antineoplastic agent	AKNAD1 CSMD1	8.09e-04	10	127	2	GO_0097327, GO_0097328
Disease	Peripheral T-Cell Lymphoma	TET2 FYN	8.09e-04	10	127	2	C0079774
Disease	nephritis (implicated_via_orthology)	ICAM1 PTK2B	8.09e-04	10	127	2	DOID:10952 (implicated_via_orthology)
Disease	psoriasis (is_marker_for)	ICAM1 MKI67 SOD2	9.06e-04	44	127	3	DOID:8893 (is_marker_for)
Disease	NG-monomethyl-arginine measurement	CSMD1 TDRD12	9.86e-04	11	127	2	EFO_0010510
Disease	attempted suicide	ADAMTSL1 CNST CCDC7 IWS1 CSMD1	1.06e-03	178	127	5	EFO_0004321
Disease	end stage renal disease (biomarker_via_orthology)	ICAM1 DDC ADIPOR1	1.10e-03	47	127	3	DOID:783 (biomarker_via_orthology)
Disease	hyperhomocysteinemia (biomarker_via_orthology)	ICAM1 SOD2	1.18e-03	12	127	2	DOID:9279 (biomarker_via_orthology)
Disease	Peripheral Nervous System Diseases	ICAM1 MKI67 SOD2	1.65e-03	54	127	3	C4721453
Disease	Waxy flexibility	TH FYN	1.86e-03	15	127	2	C0233612
Disease	Catalepsy	TH FYN	1.86e-03	15	127	2	C0007370
Disease	hypertension (is_implicated_in)	ANGPT1 PTK2B TH SOD2	1.89e-03	121	127	4	DOID:10763 (is_implicated_in)
Disease	Psoriasis	MKI67 CSMD1 SOD2	1.92e-03	57	127	3	C0033860
Disease	Pustulosis of Palms and Soles	MKI67 CSMD1 SOD2	1.92e-03	57	127	3	C0030246
Disease	optic disc size measurement	TANC2 ARID3A CLVS1 VCAN MACF1	1.98e-03	205	127	5	EFO_0004832
Disease	DiGeorge Syndrome	CRKL UFD1	2.12e-03	16	127	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	CRKL UFD1	2.12e-03	16	127	2	C0795907
Disease	central nervous system disease (implicated_via_orthology)	ACO2 TAOK2	2.12e-03	16	127	2	DOID:331 (implicated_via_orthology)
Disease	Shprintzen syndrome	CRKL UFD1	2.12e-03	16	127	2	C0220704
Disease	Pheochromocytoma, Extra-Adrenal	DDC TH	2.12e-03	16	127	2	C1257877
Disease	C-reactive protein measurement	CWF19L2 HIP1 GBX1 PDE10A PCDH17 CRK GYS2 XPNPEP3 MACF1 PLA2G6 PATJ PDLIM2 AFF4	2.13e-03	1206	127	13	EFO_0004458
Disease	susceptibility to hepatitis B infection measurement	UPB1 SPOCK1 CSMD1	2.68e-03	64	127	3	EFO_0008405
Disease	nevus count	FMN1 PLA2G6	2.69e-03	18	127	2	EFO_0004632
Disease	periodontitis	ANGPT1 TH HSP90AB2P PLEC CSMD1	2.84e-03	223	127	5	EFO_0000649
Disease	pelvic organ prolapse	ADAMTSL1 SHC3 EVX2 PLA2G6	2.88e-03	136	127	4	EFO_0004710
Disease	leukemia (implicated_via_orthology)	MEIS3 MEIS3P2	3.00e-03	19	127	2	DOID:1240 (implicated_via_orthology)
Disease	Pheochromocytoma	DDC TH	3.00e-03	19	127	2	C0031511
Disease	neuroticism measurement, cognitive function measurement	TET2 NBEAL1 ZNF385B PCDH17 PHF20L1 YLPM1 CSMD1 CBX8	3.19e-03	566	127	8	EFO_0007660, EFO_0008354
Disease	Intellectual Disability	TANC2 RTTN ACTL6A TH SACS MACF1 HNRNPR	3.29e-03	447	127	7	C3714756
Disease	fasting blood insulin measurement	TET2 HIP1 COPB2	3.32e-03	69	127	3	EFO_0004466
Disease	hyperglycemia (biomarker_via_orthology)	ICAM1 ADIPOR1	3.66e-03	21	127	2	DOID:4195 (biomarker_via_orthology)
Disease	Lewy Body Disease	TH SOD2	4.01e-03	22	127	2	C0752347
Disease	Primary microcephaly	RTTN TUBGCP6	4.01e-03	22	127	2	C0431350
Disease	portal hypertension (biomarker_via_orthology)	DDC TH	4.01e-03	22	127	2	DOID:10762 (biomarker_via_orthology)
Disease	Colonic Neoplasms	ICAM1 RCOR1 MKI67 SOD2	4.28e-03	152	127	4	C0009375

Protein segments in the cluster

Peptide	Gene	Start	Entry
LPGGSKEEEEKAKRL	ZNF385A	186	Q96PM9
KFRLEAPDADELPKG	ACO2	521	Q99798
EEAILGGEEPAKERK	ERICH3	971	Q5RHP9
AEEDGGKERHKLVLP	BAHCC1	241	Q9P281
GKDFGKFKLERQDPL	CSMD1	3456	Q96PZ7
EDIDLGSGLFEKPKA	VCAN	1176	P13611
ELLKDAIGRDIIKGP	CCDC7	1206	Q96M83
GDAEIKDGERLPLAV	COPB2	331	P35606
ALGELPAKGKFEIDT	EVX2	61	Q03828
GKKLYDALLRGEIPD	GYS2	401	P54840
DFGAERLKIPEGLFD	ACTL6A	296	O96019
LLKGGKREEEKPFRD	ANGPT1	271	Q15389
LELPKAFLNEKAGEG	DDC	126	P20711
EKAAAEEPRGGLKIE	AFF4	571	Q9UHB7
NDEEDLPFKKGDILR	CRK	146	P46108
GDPEEVGRKAELTLK	NBEAL1	256	Q6ZS30
ALKEKLDGGIEPYRL	RCOR1	361	Q9UKL0
EKEAIERLKALGFPE	RAD23B	366	P54727
GDIAKDLGLEPRELA	PCDHGA7	46	Q9Y5G6
GDGRKYPELVLDKAL	PCDHB5	186	Q9Y5E4
LDVKSRGDGTKFPEL	PCDH17	181	O14917
LEDPEGVKRFREFLK	RGS10	46	O43665
ESEKLDEAPEGKRLG	FMN1	426	Q68DA7
EKVLTGEEKALRPGD	IWS1	731	Q96ST2
GCKKELPEFEGDVLA	NIBAN3	546	Q86XR2
KEPLEAERKGGEETL	PALM3	501	A6NDB9
FGEKLKGADPEETIL	MYL2	86	P10916
RRFEKPLEEKGEGGE	SERBP1	136	Q8NC51
KAKLIGIDDVPDARG	DAB2	51	P98082
ELAELGPLLEEKGKR	ADIPOR1	26	Q96A54
VLEGKKFARLPEEEF	FLII	911	Q13045
FEGREDSILGDPKKL	MAGEA3	231	P43357
FEGREDSIFGDPKKL	MAGEA6	231	P43360
EKLHKESRGGFLPEE	KIF15	471	Q9NS87
KDLPLRSGEGDFELV	KCNJ10	266	P78508
QKRDVKLGGLGPDFE	JHY	651	Q6NUN7
KLGGLGPDFESIRDK	JHY	656	Q6NUN7
KEGLELPEDGEEKKR	HSP90AB2P	311	Q58FF8
AKDLPGVRELFEKEP	ISY1	126	Q9ULR0
SEEEVLAGRKGGPKE	ADAMTSL1	976	Q8N6G6
SDLFDIGEEKEGKPV	PDE10A	301	Q9Y233
KFIGDEKDKRPGSLE	CWF19L2	331	Q2TBE0
GPDEAKIKALLERTG	HNRNPR	121	O43390
LEGGRPEDKLEFTFK	DGKA	106	P23743
RAPEGKKLDERIIFD	MACF1	86	O94854
PGLDSDGLKREKDEI	MEIS3	46	Q99687
VKELEKSGGAEEPRG	GOLGA6L19	466	H0YKK7
GLGPKADRLEELVEE	TUBGCP6	81	Q96RT7
DLRLPEGDLGKEIEQ	EIF5A	111	P63241
PKLGRGVLEGDDVLF	MCM10	626	Q7L590
KGKSEVPEDLAGFIE	MKI67	1701	P46013
GNDAEDLPFKKGEIL	CRKL	136	P46109
DGSGLEEKVRAKLVP	NASP	406	P49321
PGLDSDGLKRDKDEI	MEIS3P2	46	A8K0S8
FKEEAEKGELGLSLP	BECN2	361	A8MW95
PIRKKEELLFDDGDD	FBF1	196	Q8TES7
GGLEADELLPAREKV	GBX1	146	Q14549
GDIDAFLKVPRPDGK	IFT46	111	Q9NQC8
DLRLPEGDLGKEIEQ	EIF5AL1	111	Q6IS14
DEGFIKEEEKPLPRN	KCNA5	216	P22460
GLGEYLKGRKLDDTP	CBX8	221	Q9HC52
LEKLRGGLEADEALP	CPZ	161	Q66K79
GREFHKPLVKEGADR	CPEB2	566	Q7Z5Q1
RGEKPLFDAGRDVLE	FBXL8	111	Q96CD0
GKELRKLDLPREAFE	UPB1	31	Q9UBR1
GKIKLIFEDGLTPDF	FAAP24	36	Q9BTP7
LDFLKDGEGRALKLP	FYN	351	P06241
KSGKPILEGAALDEA	HAUS3	66	Q68CZ6
FDPERKVEGEIFKLE	AKNAD1	456	Q5T1N1
LRGEKELKREPAVGE	ICAM1	151	P05362
NKDVIGVLEKGDRLP	PTK2B	631	Q14289
VRKEDLGSLGKVDPL	GPRIN1	206	Q7Z2K8
EPEALVGKLNRGFLE	FDXACB1	221	Q9BRP7
IGEVLGKKLEERGFD	BANF1	26	O75531
ADGFGLDILPKLKDV	FMN2	1511	Q9NZ56
LGRKKGAKLTPEEEE	RPS8	121	P62241
PEGRVAKLFDIKDGR	SACS	2116	Q9NZJ4
RDEQAFLGKDKKIPG	CNST	96	Q6PJW8
KEGFRELLLVKGAPE	PACRGL	136	Q8N7B6
EGRKFPELVLDKPLD	PCDHB6	186	Q9Y5E3
PALRKEGLKDEEDFF	PHF20L1	71	A8MW92
GDAGLVPSKKARLEE	IER2	131	Q9BTL4
KEVKDAEIPEGAARG	IRS4	671	O14654
DILVDGKAGKFDIIP	P2RX1	316	P51575
DLFIGKKPIELRLDD	RTTN	806	Q86VV8
VGGELIDPADDRKLI	USP9X	936	Q93008
VKKGLAPEVADRIGD	HARS2	256	P49590
GDPEKLGEFLQKDNI	PHF7	41	Q9BWX1
GVLEAKEDKKAGRPL	TDRD12	826	Q587J7
KKLSEVGRREPEELG	ODAD4	636	Q96NG3
KAIGEELLPRGLDIK	HIP1	761	O00291
RKEAEGLLEKDGDFL	SHC3	506	Q92529
DKLDDDGLIAPGVRV	POLR2B	846	P30876
GIQEKGKEELPARAE	SLC5A11	626	Q8WWX8
LKKFPREGFGEDLKT	TANC2	1271	Q9HCD6
KDDPEKLFSDLREIG	TAOK2	21	Q9UL54
KKNPVKFEGGDRDLE	PDIA4	611	P13667
ESGPLEEFLKREFGE	PLA2G6	556	O60733
KPELLEGIREDFKLK	PM20D2	411	Q8IYS1
GKAKDADLRPGDIIV	PDLIM2	36	Q96JY6
PEELFTKLDRIGKGS	STK25	16	O00506
LPGLEEDKAFQKEIG	SRP68	441	Q9UHB9
GEFEPDGCLKIIDRK	ACSL3	566	O95573
DGDPKRKEFLDDLFS	ARID3A	236	Q99856
RRGAKPEGKAIIDEF	NCAPD2	1271	Q15021
FKADDPGIKRALIDG	CLVS1	111	Q8IUQ0
KAKEALLLREDPGAG	TNRC18	2476	O15417
LLGKVDDGTGREAPK	ZFHX2	1946	Q9C0A1
CLEDFKGKDELGVLP	RNF122	96	Q9H9V4
FKEELVDEPFLDLGK	PATJ	821	Q8NI35
ERELGPKDKEGKLRV	SPOCK1	401	Q08629
GRKGDKLAFVEEKAP	SENP8	141	Q96LD8
FLQEGLEKGDEELRP	SEZ6	76	Q53EL9
GEPKGELLEAIKRDF	SOD2	111	P04179
FLRGFEEKGIKNDRP	ZNF385B	6	Q569K4
GIVGPEFKDKLLSAE	PLEC	4131	Q15149
ERDDLVPFTGEKKGK	TMOD4	81	Q9NZQ9
AKLIRDKEVEFGGPA	YLPM1	1851	P49750
KRKLPAEEFLGEELA	ZBTB39	581	O15060
PLVKKVEEDEAGGRF	UFD1	276	Q92890
IPEDDKDAPEKFRGL	XPNPEP3	456	Q9NQH7
KDAPEKFRGLGVRIE	XPNPEP3	461	Q9NQH7
IRPGEDDGSRKKAEF	ZNF423	911	Q2M1K9
LQVKLEEFGRPKIDG	VAV2	396	P52735
EEFGRPKIDGELKVR	VAV2	401	P52735
FLTEDGFEKGPEELR	TST	216	Q16762
PRKFKLLGDDPKEEE	TET2	1306	Q6N021
SLGPEELGLFEDKDK	USP40	71	Q9NVE5
DDEVELFRAVPGLKL	TTC39A	411	Q5SRH9
GPGNIKKAVEEAERL	USP8	91	P40818
VVLGGEPFKENDLLK	ZFYVE16	421	Q7Z3T8
KFKARELDPRILEGG	TPX2	401	Q9ULW0
GDPLEAVAFEEKEGK	TH	96	P07101
DTDLEFVDGEGKPRL	LGI3	376	Q8N145